{
  "version": "https://jsonfeed.org/version/1.1",
  "title": "FDA novel drug approvals",
  "home_page_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
  "description": "Events collected by UnlimitedPipe 0.10.62",
  "_unlimitedpipe": {
    "schema": "unlimitedpipe.event/1",
    "generator": "UnlimitedPipe 0.10.62"
  },
  "items": [
    {
      "id": "0958ef2f759b36270087",
      "title": "FDA approves Klygefa (gefurulimab-gaks) to treat anti-acetylcholine receptor antibody-positive generalized myasthenia gravis",
      "content_text": "Novel drug approval of 11/13/2026: Klygefa (gefurulimab-gaks) to treat anti-acetylcholine receptor antibody-positive generalized myasthenia gravis.",
      "date_published": "2026-11-13T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "0958ef2f759b36270087",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Klygefa",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-11-16T18:16:27Z",
          "data": {
            "change": "added",
            "label": "FDA approves Klygefa (gefurulimab-gaks) to treat anti-acetylcholine receptor antibody-positive generalized myasthenia gravis",
            "item_type": "record",
            "summary": "added: FDA approves Klygefa (gefurulimab-gaks) to treat anti-acetylcholine receptor antibody-positive generalized myasthenia gravis",
            "after": {
              "title": "FDA approves Klygefa (gefurulimab-gaks) to treat anti-acetylcholine receptor antibody-positive generalized myasthenia gravis",
              "summary": "Novel drug approval of 11/13/2026: Klygefa (gefurulimab-gaks) to treat anti-acetylcholine receptor antibody-positive generalized myasthenia gravis.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-11-13T00:00:00Z",
              "drug": "Klygefa"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 43,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.62"
            },
            {
              "step": "filter",
              "version": "0.10.62",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.62",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-\" + replace(published_at, \"-.*$\", \"\")",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.62",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.62",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "0b6033225a200c4fe55d",
      "title": "FDA approves Pimjetmi (pimicotinib) to treat adults with symptomatic tenosynovial giant cell tumors in whom surgical resection may cause worsening functional limitation or severe morbidity",
      "content_text": "Novel drug approval of 11/13/2026: Pimjetmi (pimicotinib) to treat adults with symptomatic tenosynovial giant cell tumors in whom surgical resection may cause worsening functional limitation or severe morbidity.",
      "date_published": "2026-11-13T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "0b6033225a200c4fe55d",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Pimjetmi",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-11-16T18:16:27Z",
          "data": {
            "change": "added",
            "label": "FDA approves Pimjetmi (pimicotinib) to treat adults with symptomatic tenosynovial giant cell tumors in whom surgical resection may cause worsening functional limitation or severe morbidity",
            "item_type": "record",
            "summary": "added: FDA approves Pimjetmi (pimicotinib) to treat adults with symptomatic tenosynovial giant cell tumors in whom surgical resection may cause worsening functional limitation or severe morbidity",
            "after": {
              "title": "FDA approves Pimjetmi (pimicotinib) to treat adults with symptomatic tenosynovial giant cell tumors in whom surgical resection may cause worsening functional limitation or severe morbidity",
              "summary": "Novel drug approval of 11/13/2026: Pimjetmi (pimicotinib) to treat adults with symptomatic tenosynovial giant cell tumors in whom surgical resection may cause worsening functional limitation or severe morbidity.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-11-13T00:00:00Z",
              "drug": "Pimjetmi"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 43,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.62"
            },
            {
              "step": "filter",
              "version": "0.10.62",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.62",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-\" + replace(published_at, \"-.*$\", \"\")",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.62",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.62",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "738d45baf545bf8d057c",
      "title": "FDA approves Sunharbo (asundexian) to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke or a high-risk transient ischemic attack",
      "content_text": "Novel drug approval of 11/9/2026: Sunharbo (asundexian) to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke or a high-risk transient ischemic attack.",
      "date_published": "2026-11-09T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "738d45baf545bf8d057c",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Sunharbo",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-11-09T23:23:17Z",
          "data": {
            "change": "added",
            "label": "FDA approves Sunharbo (asundexian) to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke or a high-risk transient ischemic attack",
            "item_type": "record",
            "summary": "added: FDA approves Sunharbo (asundexian) to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke or a high-risk transient ischemic attack",
            "after": {
              "title": "FDA approves Sunharbo (asundexian) to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke or a high-risk transient ischemic attack",
              "summary": "Novel drug approval of 11/9/2026: Sunharbo (asundexian) to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke or a high-risk transient ischemic attack.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-11-09T00:00:00Z",
              "drug": "Sunharbo"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 44,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.62"
            },
            {
              "step": "filter",
              "version": "0.10.62",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.62",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-\" + replace(published_at, \"-.*$\", \"\")",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.62",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.62",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "94023d4e3df7151260c9",
      "title": "FDA approves Hibsago (bepirovirsen) to treat chronic hepatitis B virus infection in certain adults without cirrhosis, in combination with existing antiviral therapy",
      "content_text": "Novel drug approval of 10/20/2026: Hibsago (bepirovirsen) to treat chronic hepatitis B virus infection in certain adults without cirrhosis, in combination with existing antiviral therapy.",
      "date_published": "2026-10-20T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "94023d4e3df7151260c9",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Hibsago",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-11-05T09:57:46Z",
          "data": {
            "change": "added",
            "label": "FDA approves Hibsago (bepirovirsen) to treat chronic hepatitis B virus infection in certain adults without cirrhosis, in combination with existing antiviral therapy",
            "item_type": "record",
            "summary": "added: FDA approves Hibsago (bepirovirsen) to treat chronic hepatitis B virus infection in certain adults without cirrhosis, in combination with existing antiviral therapy",
            "after": {
              "title": "FDA approves Hibsago (bepirovirsen) to treat chronic hepatitis B virus infection in certain adults without cirrhosis, in combination with existing antiviral therapy",
              "summary": "Novel drug approval of 10/20/2026: Hibsago (bepirovirsen) to treat chronic hepatitis B virus infection in certain adults without cirrhosis, in combination with existing antiviral therapy.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-10-20T00:00:00Z",
              "drug": "Hibsago"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 34,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.62"
            },
            {
              "step": "filter",
              "version": "0.10.62",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.62",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-\" + replace(published_at, \"-.*$\", \"\")",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.62",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.62",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "265a5b1fe0cf959b0410",
      "title": "FDA approves Hovilpri (pritelivir) to treat adults with weakened immune systems who have mucocutaneous lesions caused by herpes simplex virus infection and have not responded to other therapies",
      "content_text": "Novel drug approval of 10/9/2026: Hovilpri (pritelivir) to treat adults with weakened immune systems who have mucocutaneous lesions caused by herpes simplex virus infection and have not responded to other therapies.",
      "date_published": "2026-10-09T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "265a5b1fe0cf959b0410",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Hovilpri",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-11-05T09:57:46Z",
          "data": {
            "change": "added",
            "label": "FDA approves Hovilpri (pritelivir) to treat adults with weakened immune systems who have mucocutaneous lesions caused by herpes simplex virus infection and have not responded to other therapies",
            "item_type": "record",
            "summary": "added: FDA approves Hovilpri (pritelivir) to treat adults with weakened immune systems who have mucocutaneous lesions caused by herpes simplex virus infection and have not responded to other therapies",
            "after": {
              "title": "FDA approves Hovilpri (pritelivir) to treat adults with weakened immune systems who have mucocutaneous lesions caused by herpes simplex virus infection and have not responded to other therapies",
              "summary": "Novel drug approval of 10/9/2026: Hovilpri (pritelivir) to treat adults with weakened immune systems who have mucocutaneous lesions caused by herpes simplex virus infection and have not responded to other therapies.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-10-09T00:00:00Z",
              "drug": "Hovilpri"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 34,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.62"
            },
            {
              "step": "filter",
              "version": "0.10.62",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.62",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-\" + replace(published_at, \"-.*$\", \"\")",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.62",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.62",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "29044f8cc5233380cb2a",
      "title": "FDA approves Emcitate (tiratricol) to treat peripheral thyrotoxicosis in patients with MCT8 deficiency",
      "content_text": "Novel drug approval of 9/28/2026: Emcitate (tiratricol) to treat peripheral thyrotoxicosis in patients with MCT8 deficiency.",
      "date_published": "2026-09-28T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "29044f8cc5233380cb2a",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Emcitate",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-28T22:55:22Z",
          "data": {
            "change": "added",
            "label": "FDA approves Emcitate (tiratricol) to treat peripheral thyrotoxicosis in patients with MCT8 deficiency",
            "item_type": "record",
            "summary": "added: FDA approves Emcitate (tiratricol) to treat peripheral thyrotoxicosis in patients with MCT8 deficiency",
            "after": {
              "title": "FDA approves Emcitate (tiratricol) to treat peripheral thyrotoxicosis in patients with MCT8 deficiency",
              "summary": "Novel drug approval of 9/28/2026: Emcitate (tiratricol) to treat peripheral thyrotoxicosis in patients with MCT8 deficiency.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-09-28T00:00:00Z",
              "drug": "Emcitate"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 64,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.29"
            },
            {
              "step": "filter",
              "version": "0.10.29",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.29",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-\" + replace(published_at, \"-.*$\", \"\")",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.29",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.29",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "f3f2db50f295e4620b81",
      "title": "FDA approves Atebrioz (zilurgisertib) to reduce the volume of total new heterotopic ossification in adults and pediatric patients 12 years and older with fibrodysplasia ossificans progressiva",
      "content_text": "Novel drug approval of 9/25/2026: Atebrioz (zilurgisertib) to reduce the volume of total new heterotopic ossification in adults and pediatric patients 12 years and older with fibrodysplasia ossificans progressiva.",
      "date_published": "2026-09-25T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "f3f2db50f295e4620b81",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Atebrioz",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Atebrioz (zilurgisertib) to reduce the volume of total new heterotopic ossification in adults and pediatric patients 12 years and older with fibrodysplasia ossificans progressiva",
            "item_type": "record",
            "summary": "added: FDA approves Atebrioz (zilurgisertib) to reduce the volume of total new heterotopic ossification in adults and pediatric patients 12 years and older with fibrodysplasia ossificans progressiva",
            "after": {
              "title": "FDA approves Atebrioz (zilurgisertib) to reduce the volume of total new heterotopic ossification in adults and pediatric patients 12 years and older with fibrodysplasia ossificans progressiva",
              "summary": "Novel drug approval of 9/25/2026: Atebrioz (zilurgisertib) to reduce the volume of total new heterotopic ossification in adults and pediatric patients 12 years and older with fibrodysplasia ossificans progressiva.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-09-25T00:00:00Z",
              "drug": "Atebrioz"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "bbcad89f0abfdb0ce123",
      "title": "FDA approves Juvmo (tavapadon) to treat Parkinson’s disease in adults",
      "content_text": "Novel drug approval of 9/25/2026: Juvmo (tavapadon) to treat Parkinson’s disease in adults.",
      "date_published": "2026-09-25T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "bbcad89f0abfdb0ce123",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Juvmo",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Juvmo (tavapadon) to treat Parkinson’s disease in adults",
            "item_type": "record",
            "summary": "added: FDA approves Juvmo (tavapadon) to treat Parkinson’s disease in adults",
            "after": {
              "title": "FDA approves Juvmo (tavapadon) to treat Parkinson’s disease in adults",
              "summary": "Novel drug approval of 9/25/2026: Juvmo (tavapadon) to treat Parkinson’s disease in adults.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-09-25T00:00:00Z",
              "drug": "Juvmo"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "278e7116d5b7d4cfef42",
      "title": "FDA approves Lyrfigtu (lirafugratinib) for adults with previously treated unresectable, locally advanced or metastatic cholangiocarcinoma harboring a fibroblast growth factor receptor 2 gene…",
      "content_text": "Novel drug approval of 9/23/2026: Lyrfigtu (lirafugratinib) for adults with previously treated unresectable, locally advanced or metastatic cholangiocarcinoma harboring a fibroblast growth factor receptor 2 gene fusion or other rearrangement.",
      "date_published": "2026-09-23T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "278e7116d5b7d4cfef42",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Lyrfigtu",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Lyrfigtu (lirafugratinib) for adults with previously treated unresectable, locally advanced or metastatic cholangiocarcinoma harboring a fibroblast growth factor receptor 2 gene…",
            "item_type": "record",
            "summary": "added: FDA approves Lyrfigtu (lirafugratinib) for adults with previously treated unresectable, locally advanced or metastatic cholangiocarcinoma harboring a fibroblast growth factor receptor 2 gene…",
            "after": {
              "title": "FDA approves Lyrfigtu (lirafugratinib) for adults with previously treated unresectable, locally advanced or metastatic cholangiocarcinoma harboring a fibroblast growth factor receptor 2 gene…",
              "summary": "Novel drug approval of 9/23/2026: Lyrfigtu (lirafugratinib) for adults with previously treated unresectable, locally advanced or metastatic cholangiocarcinoma harboring a fibroblast growth factor receptor 2 gene fusion or other rearrangement.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-09-23T00:00:00Z",
              "drug": "Lyrfigtu"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "a635f5b10e9f4acface5",
      "title": "FDA approves Onswik (insulin efsitora alfa-gobe) to improve glycemic control in adults with type 2 diabetes mellitus, as an adjunct to diet and exercise",
      "content_text": "Novel drug approval of 9/23/2026: Onswik (insulin efsitora alfa-gobe) to improve glycemic control in adults with type 2 diabetes mellitus, as an adjunct to diet and exercise.",
      "date_published": "2026-09-23T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "a635f5b10e9f4acface5",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Onswik",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Onswik (insulin efsitora alfa-gobe) to improve glycemic control in adults with type 2 diabetes mellitus, as an adjunct to diet and exercise",
            "item_type": "record",
            "summary": "added: FDA approves Onswik (insulin efsitora alfa-gobe) to improve glycemic control in adults with type 2 diabetes mellitus, as an adjunct to diet and exercise",
            "after": {
              "title": "FDA approves Onswik (insulin efsitora alfa-gobe) to improve glycemic control in adults with type 2 diabetes mellitus, as an adjunct to diet and exercise",
              "summary": "Novel drug approval of 9/23/2026: Onswik (insulin efsitora alfa-gobe) to improve glycemic control in adults with type 2 diabetes mellitus, as an adjunct to diet and exercise.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-09-23T00:00:00Z",
              "drug": "Onswik"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "1ef03dbdae492fbcc86c",
      "title": "FDA approves Pixclara (floretyrosine F 18) to use with positron emission tomography to differentiate recurrent or progressive glioma from treatment-related change in conjunction with other diagnostic…",
      "content_text": "Novel drug approval of 9/11/2026: Pixclara (floretyrosine F 18) to use with positron emission tomography to differentiate recurrent or progressive glioma from treatment-related change in conjunction with other diagnostic evaluations.",
      "date_published": "2026-09-11T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "1ef03dbdae492fbcc86c",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Pixclara",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Pixclara (floretyrosine F 18) to use with positron emission tomography to differentiate recurrent or progressive glioma from treatment-related change in conjunction with other diagnostic…",
            "item_type": "record",
            "summary": "added: FDA approves Pixclara (floretyrosine F 18) to use with positron emission tomography to differentiate recurrent or progressive glioma from treatment-related change in conjunction with other diagnostic…",
            "after": {
              "title": "FDA approves Pixclara (floretyrosine F 18) to use with positron emission tomography to differentiate recurrent or progressive glioma from treatment-related change in conjunction with other diagnostic…",
              "summary": "Novel drug approval of 9/11/2026: Pixclara (floretyrosine F 18) to use with positron emission tomography to differentiate recurrent or progressive glioma from treatment-related change in conjunction with other diagnostic evaluations.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-09-11T00:00:00Z",
              "drug": "Pixclara"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "b9ae0b97ab6a485a396b",
      "title": "FDA approves Isembyld (apitegromab-mstn) to treat spinal muscular atrophy in adults and pediatric patients 2 years of age and older who are currently receiving an SMN2-targeted treatment",
      "content_text": "Novel drug approval of 9/11/2026: Isembyld (apitegromab-mstn) to treat spinal muscular atrophy in adults and pediatric patients 2 years of age and older who are currently receiving an SMN2-targeted treatment.",
      "date_published": "2026-09-11T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "b9ae0b97ab6a485a396b",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Isembyld",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Isembyld (apitegromab-mstn) to treat spinal muscular atrophy in adults and pediatric patients 2 years of age and older who are currently receiving an SMN2-targeted treatment",
            "item_type": "record",
            "summary": "added: FDA approves Isembyld (apitegromab-mstn) to treat spinal muscular atrophy in adults and pediatric patients 2 years of age and older who are currently receiving an SMN2-targeted treatment",
            "after": {
              "title": "FDA approves Isembyld (apitegromab-mstn) to treat spinal muscular atrophy in adults and pediatric patients 2 years of age and older who are currently receiving an SMN2-targeted treatment",
              "summary": "Novel drug approval of 9/11/2026: Isembyld (apitegromab-mstn) to treat spinal muscular atrophy in adults and pediatric patients 2 years of age and older who are currently receiving an SMN2-targeted treatment.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-09-11T00:00:00Z",
              "drug": "Isembyld"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "dcb80a68bbf5d9ff84d8",
      "title": "FDA approves Etcamah (camizestrant) to treat hormone receptor-positive, human epidermal growth factor receptor 2-negative, locally advanced or metastatic breast cancer upon detection of ESR1…",
      "content_text": "Novel drug approval of 9/4/2026: Etcamah (camizestrant) to treat hormone receptor-positive, human epidermal growth factor receptor 2-negative, locally advanced or metastatic breast cancer upon detection of ESR1 mutation during aromatase inhibitor and CDK4/6 inhibitor therapy.",
      "date_published": "2026-09-04T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "dcb80a68bbf5d9ff84d8",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Etcamah",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Etcamah (camizestrant) to treat hormone receptor-positive, human epidermal growth factor receptor 2-negative, locally advanced or metastatic breast cancer upon detection of ESR1…",
            "item_type": "record",
            "summary": "added: FDA approves Etcamah (camizestrant) to treat hormone receptor-positive, human epidermal growth factor receptor 2-negative, locally advanced or metastatic breast cancer upon detection of ESR1…",
            "after": {
              "title": "FDA approves Etcamah (camizestrant) to treat hormone receptor-positive, human epidermal growth factor receptor 2-negative, locally advanced or metastatic breast cancer upon detection of ESR1…",
              "summary": "Novel drug approval of 9/4/2026: Etcamah (camizestrant) to treat hormone receptor-positive, human epidermal growth factor receptor 2-negative, locally advanced or metastatic breast cancer upon detection of ESR1 mutation during aromatase inhibitor and CDK4/6 inhibitor therapy.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-09-04T00:00:00Z",
              "drug": "Etcamah"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "e866f2314e7c5aaca84b",
      "title": "FDA approves Zanvastro (zilganersen) to treat Alexander disease in pediatric and adult patients",
      "content_text": "Novel drug approval of 9/3/2026: Zanvastro (zilganersen) to treat Alexander disease in pediatric and adult patients.",
      "date_published": "2026-09-03T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "e866f2314e7c5aaca84b",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Zanvastro",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Zanvastro (zilganersen) to treat Alexander disease in pediatric and adult patients",
            "item_type": "record",
            "summary": "added: FDA approves Zanvastro (zilganersen) to treat Alexander disease in pediatric and adult patients",
            "after": {
              "title": "FDA approves Zanvastro (zilganersen) to treat Alexander disease in pediatric and adult patients",
              "summary": "Novel drug approval of 9/3/2026: Zanvastro (zilganersen) to treat Alexander disease in pediatric and adult patients.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-09-03T00:00:00Z",
              "drug": "Zanvastro"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "dc253e1141a9212348ed",
      "title": "FDA approves Mimrylo (rusfertide) to treat erythrocytosis in adults with polycythemia vera",
      "content_text": "Novel drug approval of 8/28/2026: Mimrylo (rusfertide) to treat erythrocytosis in adults with polycythemia vera.",
      "date_published": "2026-08-28T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "dc253e1141a9212348ed",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Mimrylo",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Mimrylo (rusfertide) to treat erythrocytosis in adults with polycythemia vera",
            "item_type": "record",
            "summary": "added: FDA approves Mimrylo (rusfertide) to treat erythrocytosis in adults with polycythemia vera",
            "after": {
              "title": "FDA approves Mimrylo (rusfertide) to treat erythrocytosis in adults with polycythemia vera",
              "summary": "Novel drug approval of 8/28/2026: Mimrylo (rusfertide) to treat erythrocytosis in adults with polycythemia vera.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-08-28T00:00:00Z",
              "drug": "Mimrylo"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "0a29d3774254aa74d946",
      "title": "FDA approves Lisraya (brepocitinib) to treat dermatomyositis in adults",
      "content_text": "Novel drug approval of 8/27/2026: Lisraya (brepocitinib) to treat dermatomyositis in adults.",
      "date_published": "2026-08-27T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "0a29d3774254aa74d946",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Lisraya",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Lisraya (brepocitinib) to treat dermatomyositis in adults",
            "item_type": "record",
            "summary": "added: FDA approves Lisraya (brepocitinib) to treat dermatomyositis in adults",
            "after": {
              "title": "FDA approves Lisraya (brepocitinib) to treat dermatomyositis in adults",
              "summary": "Novel drug approval of 8/27/2026: Lisraya (brepocitinib) to treat dermatomyositis in adults.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-08-27T00:00:00Z",
              "drug": "Lisraya"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "d273401a08340a485b54",
      "title": "FDA approves Rasonque (daraxonrasib) to treat metastatic pancreatic cancer",
      "content_text": "Novel drug approval of 8/26/2026: Rasonque (daraxonrasib) to treat metastatic pancreatic cancer.",
      "date_published": "2026-08-26T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "d273401a08340a485b54",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Rasonque",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Rasonque (daraxonrasib) to treat metastatic pancreatic cancer",
            "item_type": "record",
            "summary": "added: FDA approves Rasonque (daraxonrasib) to treat metastatic pancreatic cancer",
            "after": {
              "title": "FDA approves Rasonque (daraxonrasib) to treat metastatic pancreatic cancer",
              "summary": "Novel drug approval of 8/26/2026: Rasonque (daraxonrasib) to treat metastatic pancreatic cancer.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-08-26T00:00:00Z",
              "drug": "Rasonque"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "5aa87a0fc9ff4d93e5f2",
      "title": "FDA approves Pasatru (garetosmab-grts) to reduce new heterotopic ossification and clinician-assessed disease flare-ups in adults with fibrodysplasia ossificans progressiva",
      "content_text": "Novel drug approval of 8/19/2026: Pasatru (garetosmab-grts) to reduce new heterotopic ossification and clinician-assessed disease flare-ups in adults with fibrodysplasia ossificans progressiva.",
      "date_published": "2026-08-19T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "5aa87a0fc9ff4d93e5f2",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Pasatru",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Pasatru (garetosmab-grts) to reduce new heterotopic ossification and clinician-assessed disease flare-ups in adults with fibrodysplasia ossificans progressiva",
            "item_type": "record",
            "summary": "added: FDA approves Pasatru (garetosmab-grts) to reduce new heterotopic ossification and clinician-assessed disease flare-ups in adults with fibrodysplasia ossificans progressiva",
            "after": {
              "title": "FDA approves Pasatru (garetosmab-grts) to reduce new heterotopic ossification and clinician-assessed disease flare-ups in adults with fibrodysplasia ossificans progressiva",
              "summary": "Novel drug approval of 8/19/2026: Pasatru (garetosmab-grts) to reduce new heterotopic ossification and clinician-assessed disease flare-ups in adults with fibrodysplasia ossificans progressiva.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-08-19T00:00:00Z",
              "drug": "Pasatru"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "e822fe516998998dd50d",
      "title": "FDA approves Zenbexus (iberdomide) to be used in combination with daratumumab and hyaluronidase-fihj and dexamethasone for adults with multiple myeloma who have received at least one prior…",
      "content_text": "Novel drug approval of 8/13/2026: Zenbexus (iberdomide) to be used in combination with daratumumab and hyaluronidase-fihj and dexamethasone for adults with multiple myeloma who have received at least one prior line of therapy, including a proteasome inhibitor and an immunomodulatory agent.",
      "date_published": "2026-08-13T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "e822fe516998998dd50d",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Zenbexus",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Zenbexus (iberdomide) to be used in combination with daratumumab and hyaluronidase-fihj and dexamethasone for adults with multiple myeloma who have received at least one prior…",
            "item_type": "record",
            "summary": "added: FDA approves Zenbexus (iberdomide) to be used in combination with daratumumab and hyaluronidase-fihj and dexamethasone for adults with multiple myeloma who have received at least one prior…",
            "after": {
              "title": "FDA approves Zenbexus (iberdomide) to be used in combination with daratumumab and hyaluronidase-fihj and dexamethasone for adults with multiple myeloma who have received at least one prior…",
              "summary": "Novel drug approval of 8/13/2026: Zenbexus (iberdomide) to be used in combination with daratumumab and hyaluronidase-fihj and dexamethasone for adults with multiple myeloma who have received at least one prior line of therapy, including a proteasome inhibitor and an immunomodulatory agent.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-08-13T00:00:00Z",
              "drug": "Zenbexus"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "083939f0d51097db39bf",
      "title": "FDA approves Tauklarify (florquinitau F 18) to be used for positron emission tomography of the brain in adults with cognitive impairment who are being evaluated for Alzheimer disease to identify…",
      "content_text": "Novel drug approval of 8/13/2026: Tauklarify (florquinitau F 18) to be used for positron emission tomography of the brain in adults with cognitive impairment who are being evaluated for Alzheimer disease to identify patients with tau neurofibrillary tangle pathology.",
      "date_published": "2026-08-13T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "083939f0d51097db39bf",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Tauklarify",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Tauklarify (florquinitau F 18) to be used for positron emission tomography of the brain in adults with cognitive impairment who are being evaluated for Alzheimer disease to identify…",
            "item_type": "record",
            "summary": "added: FDA approves Tauklarify (florquinitau F 18) to be used for positron emission tomography of the brain in adults with cognitive impairment who are being evaluated for Alzheimer disease to identify…",
            "after": {
              "title": "FDA approves Tauklarify (florquinitau F 18) to be used for positron emission tomography of the brain in adults with cognitive impairment who are being evaluated for Alzheimer disease to identify…",
              "summary": "Novel drug approval of 8/13/2026: Tauklarify (florquinitau F 18) to be used for positron emission tomography of the brain in adults with cognitive impairment who are being evaluated for Alzheimer disease to identify patients with tau neurofibrillary tangle pathology.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-08-13T00:00:00Z",
              "drug": "Tauklarify"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "c2298d2450cbf0848b49",
      "title": "FDA approves Orzeyful (oveporexton) to treat narcolepsy type 1",
      "content_text": "Novel drug approval of 8/5/2026: Orzeyful (oveporexton) to treat narcolepsy type 1.",
      "date_published": "2026-08-05T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "c2298d2450cbf0848b49",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Orzeyful",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Orzeyful (oveporexton) to treat narcolepsy type 1",
            "item_type": "record",
            "summary": "added: FDA approves Orzeyful (oveporexton) to treat narcolepsy type 1",
            "after": {
              "title": "FDA approves Orzeyful (oveporexton) to treat narcolepsy type 1",
              "summary": "Novel drug approval of 8/5/2026: Orzeyful (oveporexton) to treat narcolepsy type 1.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-08-05T00:00:00Z",
              "drug": "Orzeyful"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "db41d78d60053e49d637",
      "title": "FDA approves Simtriyo (centanafadine) to treat attention-deficit hyperactivity disorder",
      "content_text": "Novel drug approval of 7/24/2026: Simtriyo (centanafadine) to treat attention-deficit hyperactivity disorder.",
      "date_published": "2026-07-24T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "db41d78d60053e49d637",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Simtriyo",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Simtriyo (centanafadine) to treat attention-deficit hyperactivity disorder",
            "item_type": "record",
            "summary": "added: FDA approves Simtriyo (centanafadine) to treat attention-deficit hyperactivity disorder",
            "after": {
              "title": "FDA approves Simtriyo (centanafadine) to treat attention-deficit hyperactivity disorder",
              "summary": "Novel drug approval of 7/24/2026: Simtriyo (centanafadine) to treat attention-deficit hyperactivity disorder.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-07-24T00:00:00Z",
              "drug": "Simtriyo"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "40ab2dce4307f19f79a0",
      "title": "FDA approves Lytenava (bevacizumab-vikg) to treat patients with neovascular (wet) age-related macular degeneration",
      "content_text": "Novel drug approval of 7/24/2026: Lytenava (bevacizumab-vikg) to treat patients with neovascular (wet) age-related macular degeneration.",
      "date_published": "2026-07-24T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "40ab2dce4307f19f79a0",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Lytenava",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Lytenava (bevacizumab-vikg) to treat patients with neovascular (wet) age-related macular degeneration",
            "item_type": "record",
            "summary": "added: FDA approves Lytenava (bevacizumab-vikg) to treat patients with neovascular (wet) age-related macular degeneration",
            "after": {
              "title": "FDA approves Lytenava (bevacizumab-vikg) to treat patients with neovascular (wet) age-related macular degeneration",
              "summary": "Novel drug approval of 7/24/2026: Lytenava (bevacizumab-vikg) to treat patients with neovascular (wet) age-related macular degeneration.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-07-24T00:00:00Z",
              "drug": "Lytenava"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "485c78e39068203f1669",
      "title": "FDA approves Jideytro (zidesamtinib) to treat adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer after receiving a ROS1 kinase inhibitor",
      "content_text": "Novel drug approval of 7/22/2026: Jideytro (zidesamtinib) to treat adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer after receiving a ROS1 kinase inhibitor.",
      "date_published": "2026-07-22T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "485c78e39068203f1669",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Jideytro",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Jideytro (zidesamtinib) to treat adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer after receiving a ROS1 kinase inhibitor",
            "item_type": "record",
            "summary": "added: FDA approves Jideytro (zidesamtinib) to treat adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer after receiving a ROS1 kinase inhibitor",
            "after": {
              "title": "FDA approves Jideytro (zidesamtinib) to treat adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer after receiving a ROS1 kinase inhibitor",
              "summary": "Novel drug approval of 7/22/2026: Jideytro (zidesamtinib) to treat adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer after receiving a ROS1 kinase inhibitor.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-07-22T00:00:00Z",
              "drug": "Jideytro"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "2386e2602ce8e5970d69",
      "title": "FDA approves Lipfendra (enlicitide decanoate) to reduce low-density lipoprotein cholesterol",
      "content_text": "Novel drug approval of 7/15/2026: Lipfendra (enlicitide decanoate) to reduce low-density lipoprotein cholesterol.",
      "date_published": "2026-07-15T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "2386e2602ce8e5970d69",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Lipfendra",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Lipfendra (enlicitide decanoate) to reduce low-density lipoprotein cholesterol",
            "item_type": "record",
            "summary": "added: FDA approves Lipfendra (enlicitide decanoate) to reduce low-density lipoprotein cholesterol",
            "after": {
              "title": "FDA approves Lipfendra (enlicitide decanoate) to reduce low-density lipoprotein cholesterol",
              "summary": "Novel drug approval of 7/15/2026: Lipfendra (enlicitide decanoate) to reduce low-density lipoprotein cholesterol.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-07-15T00:00:00Z",
              "drug": "Lipfendra"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "feb553c7ea78d5292779",
      "title": "FDA approves Revtorpyk (gedatolisib) In combination with fulvestran, to treat hormone receptor-positive, human epidermal growth factor receptor 2-negative, locally advanced or metastatic breast…",
      "content_text": "Novel drug approval of 7/14/2026: Revtorpyk (gedatolisib) In combination with fulvestran, to treat hormone receptor-positive, human epidermal growth factor receptor 2-negative, locally advanced or metastatic breast cancer without a PIK3CA mutation detected following progression on or after treatment with at least one line of endocrine therapy in the metastatic setting.",
      "date_published": "2026-07-14T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "feb553c7ea78d5292779",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Revtorpyk",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Revtorpyk (gedatolisib) In combination with fulvestran, to treat hormone receptor-positive, human epidermal growth factor receptor 2-negative, locally advanced or metastatic breast…",
            "item_type": "record",
            "summary": "added: FDA approves Revtorpyk (gedatolisib) In combination with fulvestran, to treat hormone receptor-positive, human epidermal growth factor receptor 2-negative, locally advanced or metastatic breast…",
            "after": {
              "title": "FDA approves Revtorpyk (gedatolisib) In combination with fulvestran, to treat hormone receptor-positive, human epidermal growth factor receptor 2-negative, locally advanced or metastatic breast…",
              "summary": "Novel drug approval of 7/14/2026: Revtorpyk (gedatolisib) In combination with fulvestran, to treat hormone receptor-positive, human epidermal growth factor receptor 2-negative, locally advanced or metastatic breast cancer without a PIK3CA mutation detected following progression on or after treatment with at least one line of endocrine therapy in the metastatic setting.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-07-14T00:00:00Z",
              "drug": "Revtorpyk"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "28ef20ce8d0f08862709",
      "title": "FDA approves Trutakna (atacicept-vymj) to reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk for disease progression",
      "content_text": "Novel drug approval of 7/7/2026: Trutakna (atacicept-vymj) to reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk for disease progression.",
      "date_published": "2026-07-07T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "28ef20ce8d0f08862709",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Trutakna",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Trutakna (atacicept-vymj) to reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk for disease progression",
            "item_type": "record",
            "summary": "added: FDA approves Trutakna (atacicept-vymj) to reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk for disease progression",
            "after": {
              "title": "FDA approves Trutakna (atacicept-vymj) to reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk for disease progression",
              "summary": "Novel drug approval of 7/7/2026: Trutakna (atacicept-vymj) to reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk for disease progression.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-07-07T00:00:00Z",
              "drug": "Trutakna"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "439649a1d3453c9a1653",
      "title": "FDA approves Lumvoa (veligrotug-vvze) to treat thyroid eye disease",
      "content_text": "Novel drug approval of 6/26/2026: Lumvoa (veligrotug-vvze) to treat thyroid eye disease.",
      "date_published": "2026-06-26T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "439649a1d3453c9a1653",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Lumvoa",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Lumvoa (veligrotug-vvze) to treat thyroid eye disease",
            "item_type": "record",
            "summary": "added: FDA approves Lumvoa (veligrotug-vvze) to treat thyroid eye disease",
            "after": {
              "title": "FDA approves Lumvoa (veligrotug-vvze) to treat thyroid eye disease",
              "summary": "Novel drug approval of 6/26/2026: Lumvoa (veligrotug-vvze) to treat thyroid eye disease.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-06-26T00:00:00Z",
              "drug": "Lumvoa"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "2dcd667cbe0f92e12f11",
      "title": "FDA approves Utebzi (tebipenem pivoxil) to treat complicated urinary tract infections, including pyelonephritis, caused by several susceptible microorganisms in adults who have limited or no…",
      "content_text": "Novel drug approval of 6/17/2026: Utebzi (tebipenem pivoxil) to treat complicated urinary tract infections, including pyelonephritis, caused by several susceptible microorganisms in adults who have limited or no alternative oral treatment options.",
      "date_published": "2026-06-17T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "2dcd667cbe0f92e12f11",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Utebzi",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Utebzi (tebipenem pivoxil) to treat complicated urinary tract infections, including pyelonephritis, caused by several susceptible microorganisms in adults who have limited or no…",
            "item_type": "record",
            "summary": "added: FDA approves Utebzi (tebipenem pivoxil) to treat complicated urinary tract infections, including pyelonephritis, caused by several susceptible microorganisms in adults who have limited or no…",
            "after": {
              "title": "FDA approves Utebzi (tebipenem pivoxil) to treat complicated urinary tract infections, including pyelonephritis, caused by several susceptible microorganisms in adults who have limited or no…",
              "summary": "Novel drug approval of 6/17/2026: Utebzi (tebipenem pivoxil) to treat complicated urinary tract infections, including pyelonephritis, caused by several susceptible microorganisms in adults who have limited or no alternative oral treatment options.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-06-17T00:00:00Z",
              "drug": "Utebzi"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "1b1a2c2ca325c2a839a6",
      "title": "FDA approves Ambelvist (gadoquatrane) to detect and visualize lesions with abnormal vascularity, in conjunction with MRI",
      "content_text": "Novel drug approval of 6/12/2026: Ambelvist (gadoquatrane) to detect and visualize lesions with abnormal vascularity, in conjunction with MRI.",
      "date_published": "2026-06-12T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "1b1a2c2ca325c2a839a6",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Ambelvist",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Ambelvist (gadoquatrane) to detect and visualize lesions with abnormal vascularity, in conjunction with MRI",
            "item_type": "record",
            "summary": "added: FDA approves Ambelvist (gadoquatrane) to detect and visualize lesions with abnormal vascularity, in conjunction with MRI",
            "after": {
              "title": "FDA approves Ambelvist (gadoquatrane) to detect and visualize lesions with abnormal vascularity, in conjunction with MRI",
              "summary": "Novel drug approval of 6/12/2026: Ambelvist (gadoquatrane) to detect and visualize lesions with abnormal vascularity, in conjunction with MRI.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-06-12T00:00:00Z",
              "drug": "Ambelvist"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "2ab0e08300e8100fe6a6",
      "title": "FDA approves Cypsedo (cipepofol) to induce general anesthesia in adults undergoing surgery",
      "content_text": "Novel drug approval of 5/29/2026: Cypsedo (cipepofol) to induce general anesthesia in adults undergoing surgery.",
      "date_published": "2026-05-29T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "2ab0e08300e8100fe6a6",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Cypsedo",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Cypsedo (cipepofol) to induce general anesthesia in adults undergoing surgery",
            "item_type": "record",
            "summary": "added: FDA approves Cypsedo (cipepofol) to induce general anesthesia in adults undergoing surgery",
            "after": {
              "title": "FDA approves Cypsedo (cipepofol) to induce general anesthesia in adults undergoing surgery",
              "summary": "Novel drug approval of 5/29/2026: Cypsedo (cipepofol) to induce general anesthesia in adults undergoing surgery.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-05-29T00:00:00Z",
              "drug": "Cypsedo"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "052bc057d6f214328d88",
      "title": "FDA approves Xocova (ensitrelvir) to use as post-exposure prophylaxis of coronavirus disease 2019 (COVID-19) following contact with an individual who has COVID-19",
      "content_text": "Novel drug approval of 5/29/2026: Xocova (ensitrelvir) to use as post-exposure prophylaxis of coronavirus disease 2019 (COVID-19) following contact with an individual who has COVID-19.",
      "date_published": "2026-05-29T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "052bc057d6f214328d88",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Xocova",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Xocova (ensitrelvir) to use as post-exposure prophylaxis of coronavirus disease 2019 (COVID-19) following contact with an individual who has COVID-19",
            "item_type": "record",
            "summary": "added: FDA approves Xocova (ensitrelvir) to use as post-exposure prophylaxis of coronavirus disease 2019 (COVID-19) following contact with an individual who has COVID-19",
            "after": {
              "title": "FDA approves Xocova (ensitrelvir) to use as post-exposure prophylaxis of coronavirus disease 2019 (COVID-19) following contact with an individual who has COVID-19",
              "summary": "Novel drug approval of 5/29/2026: Xocova (ensitrelvir) to use as post-exposure prophylaxis of coronavirus disease 2019 (COVID-19) following contact with an individual who has COVID-19.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-05-29T00:00:00Z",
              "drug": "Xocova"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "2207e79591b3dea9065b",
      "title": "FDA approves Zaynich (cefepime and zidebactam) to treat complicated urinary tract infections, including pyelonephritis, caused by designated susceptible microorganisms",
      "content_text": "Novel drug approval of 5/29/2026: Zaynich (cefepime and zidebactam) to treat complicated urinary tract infections, including pyelonephritis, caused by designated susceptible microorganisms.",
      "date_published": "2026-05-29T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "2207e79591b3dea9065b",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Zaynich",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Zaynich (cefepime and zidebactam) to treat complicated urinary tract infections, including pyelonephritis, caused by designated susceptible microorganisms",
            "item_type": "record",
            "summary": "added: FDA approves Zaynich (cefepime and zidebactam) to treat complicated urinary tract infections, including pyelonephritis, caused by designated susceptible microorganisms",
            "after": {
              "title": "FDA approves Zaynich (cefepime and zidebactam) to treat complicated urinary tract infections, including pyelonephritis, caused by designated susceptible microorganisms",
              "summary": "Novel drug approval of 5/29/2026: Zaynich (cefepime and zidebactam) to treat complicated urinary tract infections, including pyelonephritis, caused by designated susceptible microorganisms.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-05-29T00:00:00Z",
              "drug": "Zaynich"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "b99e517f51189363228a",
      "title": "FDA approves Decnupaz (pivekimab sunirine-pvzy) to treat adults with blastic plasmacytoid dendritic cell neoplasm Drug Trials Snapshot",
      "content_text": "Novel drug approval of 5/27/2026: Decnupaz (pivekimab sunirine-pvzy) to treat adults with blastic plasmacytoid dendritic cell neoplasm Drug Trials Snapshot.",
      "date_published": "2026-05-27T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "b99e517f51189363228a",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Decnupaz",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Decnupaz (pivekimab sunirine-pvzy) to treat adults with blastic plasmacytoid dendritic cell neoplasm Drug Trials Snapshot",
            "item_type": "record",
            "summary": "added: FDA approves Decnupaz (pivekimab sunirine-pvzy) to treat adults with blastic plasmacytoid dendritic cell neoplasm Drug Trials Snapshot",
            "after": {
              "title": "FDA approves Decnupaz (pivekimab sunirine-pvzy) to treat adults with blastic plasmacytoid dendritic cell neoplasm Drug Trials Snapshot",
              "summary": "Novel drug approval of 5/27/2026: Decnupaz (pivekimab sunirine-pvzy) to treat adults with blastic plasmacytoid dendritic cell neoplasm Drug Trials Snapshot.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-05-27T00:00:00Z",
              "drug": "Decnupaz"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "5ed757f253b6ad7bc753",
      "title": "FDA approves Hepcludex (bulevirtide-gmod) to treat chronic hepatitis delta virus infection in adults without cirrhosis or with compensated cirrhosis",
      "content_text": "Novel drug approval of 5/22/2026: Hepcludex (bulevirtide-gmod) to treat chronic hepatitis delta virus infection in adults without cirrhosis or with compensated cirrhosis.",
      "date_published": "2026-05-22T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "5ed757f253b6ad7bc753",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Hepcludex",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Hepcludex (bulevirtide-gmod) to treat chronic hepatitis delta virus infection in adults without cirrhosis or with compensated cirrhosis",
            "item_type": "record",
            "summary": "added: FDA approves Hepcludex (bulevirtide-gmod) to treat chronic hepatitis delta virus infection in adults without cirrhosis or with compensated cirrhosis",
            "after": {
              "title": "FDA approves Hepcludex (bulevirtide-gmod) to treat chronic hepatitis delta virus infection in adults without cirrhosis or with compensated cirrhosis",
              "summary": "Novel drug approval of 5/22/2026: Hepcludex (bulevirtide-gmod) to treat chronic hepatitis delta virus infection in adults without cirrhosis or with compensated cirrhosis.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-05-22T00:00:00Z",
              "drug": "Hepcludex"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "d688336820a348c47ea8",
      "title": "FDA approves Baxfendy (baxdrostat) to treat hypertension in combination with other antihypertensive drugs",
      "content_text": "Novel drug approval of 5/15/2026: Baxfendy (baxdrostat) to treat hypertension in combination with other antihypertensive drugs.",
      "date_published": "2026-05-15T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "d688336820a348c47ea8",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Baxfendy",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Baxfendy (baxdrostat) to treat hypertension in combination with other antihypertensive drugs",
            "item_type": "record",
            "summary": "added: FDA approves Baxfendy (baxdrostat) to treat hypertension in combination with other antihypertensive drugs",
            "after": {
              "title": "FDA approves Baxfendy (baxdrostat) to treat hypertension in combination with other antihypertensive drugs",
              "summary": "Novel drug approval of 5/15/2026: Baxfendy (baxdrostat) to treat hypertension in combination with other antihypertensive drugs.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-05-15T00:00:00Z",
              "drug": "Baxfendy"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "1b27c6a863c7994c0777",
      "title": "FDA approves Beqalzi (sonrotoclax) to treat adults with relapsed or refractory mantle cell lymphoma after at least two lines of systemic therapy, including a Bruton’s tyrosine kinase inhibitor",
      "content_text": "Novel drug approval of 5/13/2026: Beqalzi (sonrotoclax) to treat adults with relapsed or refractory mantle cell lymphoma after at least two lines of systemic therapy, including a Bruton’s tyrosine kinase inhibitor.",
      "date_published": "2026-05-13T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "1b27c6a863c7994c0777",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Beqalzi",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Beqalzi (sonrotoclax) to treat adults with relapsed or refractory mantle cell lymphoma after at least two lines of systemic therapy, including a Bruton’s tyrosine kinase inhibitor",
            "item_type": "record",
            "summary": "added: FDA approves Beqalzi (sonrotoclax) to treat adults with relapsed or refractory mantle cell lymphoma after at least two lines of systemic therapy, including a Bruton’s tyrosine kinase inhibitor",
            "after": {
              "title": "FDA approves Beqalzi (sonrotoclax) to treat adults with relapsed or refractory mantle cell lymphoma after at least two lines of systemic therapy, including a Bruton’s tyrosine kinase inhibitor",
              "summary": "Novel drug approval of 5/13/2026: Beqalzi (sonrotoclax) to treat adults with relapsed or refractory mantle cell lymphoma after at least two lines of systemic therapy, including a Bruton’s tyrosine kinase inhibitor.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-05-13T00:00:00Z",
              "drug": "Beqalzi"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "2b10d53ba45ca4f5df30",
      "title": "FDA approves Veppanu (vepdegestrant) to treat estrogen receptor-positive, human epidermal growth factor receptor 2-negative, ESR1-mutated advanced or metastatic breast cancer with disease…",
      "content_text": "Novel drug approval of 5/1/2026: Veppanu (vepdegestrant) to treat estrogen receptor-positive, human epidermal growth factor receptor 2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy.",
      "date_published": "2026-05-01T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "2b10d53ba45ca4f5df30",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Veppanu",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Veppanu (vepdegestrant) to treat estrogen receptor-positive, human epidermal growth factor receptor 2-negative, ESR1-mutated advanced or metastatic breast cancer with disease…",
            "item_type": "record",
            "summary": "added: FDA approves Veppanu (vepdegestrant) to treat estrogen receptor-positive, human epidermal growth factor receptor 2-negative, ESR1-mutated advanced or metastatic breast cancer with disease…",
            "after": {
              "title": "FDA approves Veppanu (vepdegestrant) to treat estrogen receptor-positive, human epidermal growth factor receptor 2-negative, ESR1-mutated advanced or metastatic breast cancer with disease…",
              "summary": "Novel drug approval of 5/1/2026: Veppanu (vepdegestrant) to treat estrogen receptor-positive, human epidermal growth factor receptor 2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-05-01T00:00:00Z",
              "drug": "Veppanu"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "abe165072951ad8f9771",
      "title": "FDA approves Idvynso (doravirine and islatravir) to treat HIV-1 infection (as a complete regimen) in adults to replace the current antiretroviral regimen in those who are virologically-suppressed on a…",
      "content_text": "Novel drug approval of 4/20/2026: Idvynso (doravirine and islatravir) to treat HIV-1 infection (as a complete regimen) in adults to replace the current antiretroviral regimen in those who are virologically-suppressed on a stable antiretroviral regimen with no history of virologic treatment failure and no known substitutions associated with resistance to doravirine.",
      "date_published": "2026-04-20T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "abe165072951ad8f9771",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Idvynso",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Idvynso (doravirine and islatravir) to treat HIV-1 infection (as a complete regimen) in adults to replace the current antiretroviral regimen in those who are virologically-suppressed on a…",
            "item_type": "record",
            "summary": "added: FDA approves Idvynso (doravirine and islatravir) to treat HIV-1 infection (as a complete regimen) in adults to replace the current antiretroviral regimen in those who are virologically-suppressed on a…",
            "after": {
              "title": "FDA approves Idvynso (doravirine and islatravir) to treat HIV-1 infection (as a complete regimen) in adults to replace the current antiretroviral regimen in those who are virologically-suppressed on a…",
              "summary": "Novel drug approval of 4/20/2026: Idvynso (doravirine and islatravir) to treat HIV-1 infection (as a complete regimen) in adults to replace the current antiretroviral regimen in those who are virologically-suppressed on a stable antiretroviral regimen with no history of virologic treatment failure and no known substitutions associated with resistance to doravirine.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-04-20T00:00:00Z",
              "drug": "Idvynso"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "9043ddfd6edb064e662c",
      "title": "FDA approves Foundayo (orforglipron) to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related…",
      "content_text": "Novel drug approval of 4/1/2026: Foundayo (orforglipron) to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition, in combination with a reduced-calorie diet and increased physical activity.",
      "date_published": "2026-04-01T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "9043ddfd6edb064e662c",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Foundayo",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Foundayo (orforglipron) to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related…",
            "item_type": "record",
            "summary": "added: FDA approves Foundayo (orforglipron) to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related…",
            "after": {
              "title": "FDA approves Foundayo (orforglipron) to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related…",
              "summary": "Novel drug approval of 4/1/2026: Foundayo (orforglipron) to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition, in combination with a reduced-calorie diet and increased physical activity.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-04-01T00:00:00Z",
              "drug": "Foundayo"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "d044fccbcefafe8a263b",
      "title": "FDA approves Awiqli (insulin icodec-abae) to improve glycemic control in adults with type 2 diabetes mellitus",
      "content_text": "Novel drug approval of 3/26/2026: Awiqli (insulin icodec-abae) to improve glycemic control in adults with type 2 diabetes mellitus.",
      "date_published": "2026-03-26T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "d044fccbcefafe8a263b",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Awiqli",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Awiqli (insulin icodec-abae) to improve glycemic control in adults with type 2 diabetes mellitus",
            "item_type": "record",
            "summary": "added: FDA approves Awiqli (insulin icodec-abae) to improve glycemic control in adults with type 2 diabetes mellitus",
            "after": {
              "title": "FDA approves Awiqli (insulin icodec-abae) to improve glycemic control in adults with type 2 diabetes mellitus",
              "summary": "Novel drug approval of 3/26/2026: Awiqli (insulin icodec-abae) to improve glycemic control in adults with type 2 diabetes mellitus.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-03-26T00:00:00Z",
              "drug": "Awiqli"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "83835552493f80812f78",
      "title": "FDA approves Lifyorli (relacorilant) to treat platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer after one to three prior systemic treatment regimens, at least…",
      "content_text": "Novel drug approval of 3/25/2026: Lifyorli (relacorilant) to treat platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer after one to three prior systemic treatment regimens, at least one of which included bevacizumab.",
      "date_published": "2026-03-25T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "83835552493f80812f78",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Lifyorli",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Lifyorli (relacorilant) to treat platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer after one to three prior systemic treatment regimens, at least…",
            "item_type": "record",
            "summary": "added: FDA approves Lifyorli (relacorilant) to treat platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer after one to three prior systemic treatment regimens, at least…",
            "after": {
              "title": "FDA approves Lifyorli (relacorilant) to treat platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer after one to three prior systemic treatment regimens, at least…",
              "summary": "Novel drug approval of 3/25/2026: Lifyorli (relacorilant) to treat platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer after one to three prior systemic treatment regimens, at least one of which included bevacizumab.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-03-25T00:00:00Z",
              "drug": "Lifyorli"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "1347676c44ab749554c8",
      "title": "FDA approves Avlayah (tividenofusp alfa-eknm) to treat certain individuals with Hunter syndrome (Mucopolysaccharidosis type II or MPS II)",
      "content_text": "Novel drug approval of 3/24/2026: Avlayah (tividenofusp alfa-eknm) to treat certain individuals with Hunter syndrome (Mucopolysaccharidosis type II or MPS II).",
      "date_published": "2026-03-24T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "1347676c44ab749554c8",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Avlayah",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Avlayah (tividenofusp alfa-eknm) to treat certain individuals with Hunter syndrome (Mucopolysaccharidosis type II or MPS II)",
            "item_type": "record",
            "summary": "added: FDA approves Avlayah (tividenofusp alfa-eknm) to treat certain individuals with Hunter syndrome (Mucopolysaccharidosis type II or MPS II)",
            "after": {
              "title": "FDA approves Avlayah (tividenofusp alfa-eknm) to treat certain individuals with Hunter syndrome (Mucopolysaccharidosis type II or MPS II)",
              "summary": "Novel drug approval of 3/24/2026: Avlayah (tividenofusp alfa-eknm) to treat certain individuals with Hunter syndrome (Mucopolysaccharidosis type II or MPS II).",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-03-24T00:00:00Z",
              "drug": "Avlayah"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "45377a4db051322eb842",
      "title": "FDA approves Icotyde (icotrokinra) to treat moderate-to-severe plaque psoriasis in patients 12 years and older who weigh at least 40 kg and who are candidates for systemic therapy or phototherapy…",
      "content_text": "Novel drug approval of 3/17/2026: Icotyde (icotrokinra) to treat moderate-to-severe plaque psoriasis in patients 12 years and older who weigh at least 40 kg and who are candidates for systemic therapy or phototherapy Drug Trials Snapshot.",
      "date_published": "2026-03-17T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "45377a4db051322eb842",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Icotyde",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Icotyde (icotrokinra) to treat moderate-to-severe plaque psoriasis in patients 12 years and older who weigh at least 40 kg and who are candidates for systemic therapy or phototherapy…",
            "item_type": "record",
            "summary": "added: FDA approves Icotyde (icotrokinra) to treat moderate-to-severe plaque psoriasis in patients 12 years and older who weigh at least 40 kg and who are candidates for systemic therapy or phototherapy…",
            "after": {
              "title": "FDA approves Icotyde (icotrokinra) to treat moderate-to-severe plaque psoriasis in patients 12 years and older who weigh at least 40 kg and who are candidates for systemic therapy or phototherapy…",
              "summary": "Novel drug approval of 3/17/2026: Icotyde (icotrokinra) to treat moderate-to-severe plaque psoriasis in patients 12 years and older who weigh at least 40 kg and who are candidates for systemic therapy or phototherapy Drug Trials Snapshot.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-03-17T00:00:00Z",
              "drug": "Icotyde"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "d5957fa39d3d1e153e46",
      "title": "FDA approves Lynavoy (linerixibat) to treat cholestatic pruritus associated with primary biliary cholangitis",
      "content_text": "Novel drug approval of 3/17/2026: Lynavoy (linerixibat) to treat cholestatic pruritus associated with primary biliary cholangitis.",
      "date_published": "2026-03-17T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "d5957fa39d3d1e153e46",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Lynavoy",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Lynavoy (linerixibat) to treat cholestatic pruritus associated with primary biliary cholangitis",
            "item_type": "record",
            "summary": "added: FDA approves Lynavoy (linerixibat) to treat cholestatic pruritus associated with primary biliary cholangitis",
            "after": {
              "title": "FDA approves Lynavoy (linerixibat) to treat cholestatic pruritus associated with primary biliary cholangitis",
              "summary": "Novel drug approval of 3/17/2026: Lynavoy (linerixibat) to treat cholestatic pruritus associated with primary biliary cholangitis.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-03-17T00:00:00Z",
              "drug": "Lynavoy"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "c3a322801d80f2290099",
      "title": "FDA approves Yuviwel (navepegritide) to increase linear growth in pediatric patients 2 years and older with achondroplasia with open epiphyses",
      "content_text": "Novel drug approval of 2/27/2026: Yuviwel (navepegritide) to increase linear growth in pediatric patients 2 years and older with achondroplasia with open epiphyses.",
      "date_published": "2026-02-27T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "c3a322801d80f2290099",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Yuviwel",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Yuviwel (navepegritide) to increase linear growth in pediatric patients 2 years and older with achondroplasia with open epiphyses",
            "item_type": "record",
            "summary": "added: FDA approves Yuviwel (navepegritide) to increase linear growth in pediatric patients 2 years and older with achondroplasia with open epiphyses",
            "after": {
              "title": "FDA approves Yuviwel (navepegritide) to increase linear growth in pediatric patients 2 years and older with achondroplasia with open epiphyses",
              "summary": "Novel drug approval of 2/27/2026: Yuviwel (navepegritide) to increase linear growth in pediatric patients 2 years and older with achondroplasia with open epiphyses.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-02-27T00:00:00Z",
              "drug": "Yuviwel"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "b2e3af2225729f3baf2c",
      "title": "FDA approves Loargys (pegzilarginase-nbln) to treat hyperarginemia in adults and pediatric patients two years and older with Arginase 1 Deficiency, in conjunction with dietary protein restriction",
      "content_text": "Novel drug approval of 2/23/2026: Loargys (pegzilarginase-nbln) to treat hyperarginemia in adults and pediatric patients two years and older with Arginase 1 Deficiency, in conjunction with dietary protein restriction.",
      "date_published": "2026-02-23T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "b2e3af2225729f3baf2c",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Loargys",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Loargys (pegzilarginase-nbln) to treat hyperarginemia in adults and pediatric patients two years and older with Arginase 1 Deficiency, in conjunction with dietary protein restriction",
            "item_type": "record",
            "summary": "added: FDA approves Loargys (pegzilarginase-nbln) to treat hyperarginemia in adults and pediatric patients two years and older with Arginase 1 Deficiency, in conjunction with dietary protein restriction",
            "after": {
              "title": "FDA approves Loargys (pegzilarginase-nbln) to treat hyperarginemia in adults and pediatric patients two years and older with Arginase 1 Deficiency, in conjunction with dietary protein restriction",
              "summary": "Novel drug approval of 2/23/2026: Loargys (pegzilarginase-nbln) to treat hyperarginemia in adults and pediatric patients two years and older with Arginase 1 Deficiency, in conjunction with dietary protein restriction.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-02-23T00:00:00Z",
              "drug": "Loargys"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "6dcde7c0a5902d01beae",
      "title": "FDA approves Bysanti (milsaperidone) to treat schizophrenia and to treat manic or mixed episodes associated with bipolar I disorder",
      "content_text": "Novel drug approval of 2/20/2026: Bysanti (milsaperidone) to treat schizophrenia and to treat manic or mixed episodes associated with bipolar I disorder.",
      "date_published": "2026-02-20T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "6dcde7c0a5902d01beae",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Bysanti",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Bysanti (milsaperidone) to treat schizophrenia and to treat manic or mixed episodes associated with bipolar I disorder",
            "item_type": "record",
            "summary": "added: FDA approves Bysanti (milsaperidone) to treat schizophrenia and to treat manic or mixed episodes associated with bipolar I disorder",
            "after": {
              "title": "FDA approves Bysanti (milsaperidone) to treat schizophrenia and to treat manic or mixed episodes associated with bipolar I disorder",
              "summary": "Novel drug approval of 2/20/2026: Bysanti (milsaperidone) to treat schizophrenia and to treat manic or mixed episodes associated with bipolar I disorder.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-02-20T00:00:00Z",
              "drug": "Bysanti"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "aa833e5612264850dc35",
      "title": "FDA approves Adquey (difamilast) to treat mild to moderate atopic dermatitis",
      "content_text": "Novel drug approval of 2/12/2026: Adquey (difamilast) to treat mild to moderate atopic dermatitis.",
      "date_published": "2026-02-12T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "aa833e5612264850dc35",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Adquey",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Adquey (difamilast) to treat mild to moderate atopic dermatitis",
            "item_type": "record",
            "summary": "added: FDA approves Adquey (difamilast) to treat mild to moderate atopic dermatitis",
            "after": {
              "title": "FDA approves Adquey (difamilast) to treat mild to moderate atopic dermatitis",
              "summary": "Novel drug approval of 2/12/2026: Adquey (difamilast) to treat mild to moderate atopic dermatitis.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-02-12T00:00:00Z",
              "drug": "Adquey"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    },
    {
      "id": "3763a42bbfc450c0421f",
      "title": "FDA approves Zycubo (copper histidinate) to treat Menkes disease Drug Trials Snapshot",
      "content_text": "Novel drug approval of 1/12/2026: Zycubo (copper histidinate) to treat Menkes disease Drug Trials Snapshot.",
      "date_published": "2026-01-12T00:00:00Z",
      "_unlimitedpipe": {
        "event": {
          "schema": "unlimitedpipe.event/1",
          "id": "3763a42bbfc450c0421f",
          "source": "web",
          "type": "change",
          "key": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026#Zycubo",
          "source_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
          "timestamp": null,
          "observed_at": "2026-09-27T21:54:01Z",
          "data": {
            "change": "added",
            "label": "FDA approves Zycubo (copper histidinate) to treat Menkes disease Drug Trials Snapshot",
            "item_type": "record",
            "summary": "added: FDA approves Zycubo (copper histidinate) to treat Menkes disease Drug Trials Snapshot",
            "after": {
              "title": "FDA approves Zycubo (copper histidinate) to treat Menkes disease Drug Trials Snapshot",
              "summary": "Novel drug approval of 1/12/2026: Zycubo (copper histidinate) to treat Menkes disease Drug Trials Snapshot.",
              "link": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
              "published_at": "2026-01-12T00:00:00Z",
              "drug": "Zycubo"
            }
          },
          "metadata": {
            "status": 200,
            "final_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026",
            "content_type": "text/html",
            "elapsed_ms": 118,
            "not_modified": false,
            "method": "css"
          },
          "provenance": [
            {
              "step": "web",
              "version": "0.10.7"
            },
            {
              "step": "filter",
              "version": "0.10.7",
              "args": {
                "expr": "name != \"\""
              }
            },
            {
              "step": "map",
              "version": "0.10.7",
              "args": {
                "assign": [
                  "use=replace(replace(trim(use), \"^To (adults|patients|pediatric)\", \"for \\\\1\"), \"^To \", \"to \")",
                  "title=\"FDA approves \" + trim(name) + \" (\" + trim(ingredient) + \") \" + replace(use, \"^(.{150}[^ ,]*)[ ,].+$\", \"\\\\1…\")",
                  "summary=\"Novel drug approval of \" + trim(approved) + \": \" + trim(name) + \" (\" + trim(ingredient) + \") \" + use + \".\"",
                  "published_at=date(replace(replace(replace(trim(approved), \"^(\\\\d)/\", \"0\\\\1/\"), \"/(\\\\d)/\", \"/0\\\\1/\"), \"^(\\\\d\\\\d)/(\\\\d\\\\d)/(\\\\d{4})$\", \"\\\\3-\\\\1-\\\\2\"))",
                  "link=\"https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026\"",
                  "drug=trim(name)"
                ]
              }
            },
            {
              "step": "select",
              "version": "0.10.7",
              "args": {
                "fields": [
                  "title",
                  "summary",
                  "link",
                  "published_at",
                  "drug"
                ]
              }
            },
            {
              "step": "diff",
              "version": "0.10.7",
              "args": {
                "key": "drug",
                "namespace": "drug-approvals",
                "only": [
                  "added"
                ],
                "emit_initial": true,
                "remember": true
              }
            }
          ]
        }
      },
      "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026"
    }
  ]
}
